ABOUT US

Neopharmed Gentili is an Italian pharmaceutical company and is currently expanding internationally.
We specialize in bringing to market solutions of high therapeutic value, with the aim of helping people lead healthier and longer lives, as a result of our commitment across multiple therapeutic areas.

50

50+ years of experience in the field

10

Scientific knowhow in 10+ therapeutic areas

3M

3+ million patients treated in 2024

THERAPEUTIC

AREAS

CARDIO METABOLIC AREA

VASCULAR AREA

NEUROPSYCHIATRY

RARE DISEASES

PULMUNARY-ALLERGOLOCICAL

OTORHINOLARYNGOLOGY

PEDIATRICS

GASTROENTEROLOGICAL

OSTEOARTICULAR AREA

ANTIBIOTIC

UROLOGY

LATEST NEWS

26 June 2026

CHMP issues a positive opinion on the paediatric extension of berotralstat for the treatment of hereditary angioedema

BioCryst Ireland, a Neopharmed Gentili company, announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the extension of the indication for berotralstat for the routine prophylaxis of recurrent attacks of hereditary angioedema (HAE) in children aged 2 to less than 12 years.

READ MORE

PRODUCTS

Improving people’s lives, no matter what stage of illness they are in. We strive to restore quality of life to those facing the challenges of a therapeutic journey. Care, precision, professionalism, and great expertise are the values that drive our research and goals.

DISCOVER OUR LINE OF MEDICATIONS

INVESTORS

Neopharmed Gentili is an Italian company that is rapidly expanding abroad. Thanks to a policy of acquiring the best active ingredients for the most demanding therapeutic pathways, it represents a particularly attractive investment asset.

READ MORE

HCP

Organized by therapeutic areas, in this section, accredited physicians can download all informational materials and specific updates related to each medicine distributed by Neopharmed Gentili.

READ ALL INFORMATION AND SERVICES